$VNRX
Volitionrx Ltd
NYSE · Healthcare · In Vitro & In Vivo Diagnostic Substances · Henderson, NV
VNRX chart
What traders are saying about $VNRX
Latest postsVolitionrx Ltd news
- VolitionRx Limited (VNRX) stock price, news, quote and history
Yahoo Finance UK ·
- VolitionRx Limited Schedules Third Quarter 2026 Earnings Conference Call and Business Update
Yahoo Finance ·
- A Nov. 13 call will cover VolitionRx's results and upcoming milestones.
Stock Titan ·
- VolitionRX (VNRX) Stock Price, News & Analysis
MarketBeat ·
- VolitionRx (NYSEAM:VNRX) - Stock Analysis
Simply Wall St ·
- VolitionRx Signs LOI with Missionpharma to explore the Development and Launch of Volition's Lateral Flow Technology for NETosis Worldwide
Yahoo Finance ·
- VolitionRx Limited Announces $500,000 Partial Pre-Payment of Convertible Note in Cash
Yahoo Finance ·
- VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France
Yahoo Finance ·
- VolitionRx Participates in Launch of DETECSEPS Program in France
Yahoo Finance ·
- VNRX: VolitionRx Prepays Outstanding Balance on the $7,500,000 Lind Senior Secured Convertible Promissory Note Dated May 20, 2025. Review of Papers, Posters, and Videos Released in Mid-2026. Sysmex Collaboration is the 3rd Recent Agreement in the Human Space.
Yahoo Finance ·
- VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027
Yahoo Finance ·
- Volition Presents Early Stage I Solid Cancer Detection at the ESMO MAP Conference
Yahoo Finance ·
Volitionrx Ltd key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $1.7M | $1.2M | $775,302 | $306,392 |
| Net income | -$23.4M | -$27.0M | -$35.7M | -$30.6M |
| Diluted EPS | – | $-0.31 | $-0.50 | – |
| Total assets (year end) | $6.9M | $9.4M | $28.0M | $18.3M |
| Cash and equivalents (year end) | $1.1M | $3.3M | $20.7M | $10.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Volitionrx Ltd
- Ticker
- VNRX (NYSE)
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Headquarters
- Henderson, NV
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 93314
- Former names
- VOLITIONRX LTD, STANDARD CAPITAL CORP
Frequently asked questions
What exchange is Volitionrx Ltd listed on?
Volitionrx Ltd trades on the NYSE under the ticker symbol VNRX.
What industry is Volitionrx Ltd in?
Volitionrx Ltd is classified by the SEC under "In Vitro & In Vivo Diagnostic Substances", part of the Healthcare sector on StockTweeting.
Where is Volitionrx Ltd headquartered?
Volitionrx Ltd's business address on file with the SEC is in Henderson, NV.
When does Volitionrx Ltd's fiscal year end?
Volitionrx Ltd's fiscal year ends on December 31.
How much revenue did Volitionrx Ltd report?
Volitionrx Ltd reported $1.7M in revenue for calendar year 2025, according to its SEC filings.